Sensulin Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4M

  • Investors
  • 18

Sensulin General Information

Description

Developer of glucose-responsive insulin designed for treating diabetes. The company's insulin helps to eliminate the need for separate basal and prandial insulin and reduce the need for glucose monitoring, enabling patients suffering from diabetes to eliminate the need for multiple injections daily.

Contact Information

Formerly Known As
Cense Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 East California
  • Suite 200
  • Oklahoma City, OK 73104
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 12 East California
  • Suite 200
  • Oklahoma City, OK 73104
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensulin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Sep-2021 $4M Completed Pre-Clinical Trials
6. Later Stage VC (Series B) 23-May-2018 Completed Product Development
5. Later Stage VC (Series A) 13-Jan-2016 Completed Product Development
4. Grant 01-Dec-2013 Completed Startup
3. Seed Round 28-Feb-2013 Completed Startup
2. Accelerator/Incubator 01-Jan-2013 $500K $500K Completed Startup
1. Angel (individual) 25-Apr-2012 Completed Startup
To view Sensulin’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sensulin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of glucose-responsive insulin designed for treating diabetes. The company's insulin helps to eliminate the nee
Drug Discovery
Oklahoma City, OK
6 As of 2026

Mississauga, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sensulin Competitors (1)

One of Sensulin’s competitors is Sernova Biotherapeutics, a Corporation company based in Mississauga, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sernova Biotherapeutics Corporation Mississauga, Canada
You’re viewing 1 of 1 competitors. Get the full list »

Sensulin Patents

Sensulin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012223210-A1 Vesicle compositions Active 02-Mar-2011
AU-2012223210-B2 Vesicle compositions Inactive 02-Mar-2011
CA-2822021-A1 Vesicle compositions Active 02-Mar-2011
CA-2822021-C Vesicle compositions Active 02-Mar-2011
EP-2680822-A1 Vesicle compositions Active 02-Mar-2011 A61K38/28
To view Sensulin’s complete patent history, request access »

Sensulin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensulin Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Century Venture Partners Venture Capital Minority
Cortado Ventures Venture Capital Minority
StartUp Health Venture Capital Minority
Angel (individual) Minority
AngelMD Angel Group Minority
You’re viewing 5 of 18 investors. Get the full list »

Sensulin FAQs

  • When was Sensulin founded?

    Sensulin was founded in 2011.

  • Where is Sensulin headquartered?

    Sensulin is headquartered in Oklahoma City, OK.

  • What is the size of Sensulin?

    Sensulin has 6 total employees.

  • What industry is Sensulin in?

    Sensulin’s primary industry is Drug Discovery.

  • Is Sensulin a private or public company?

    Sensulin is a Private company.

  • What is Sensulin’s current revenue?

    The current revenue for Sensulin is .

  • How much funding has Sensulin raised over time?

    Sensulin has raised $7.83M.

  • Who are Sensulin’s investors?

    Century Venture Partners, Cortado Ventures, StartUp Health, , and AngelMD are 5 of 18 investors who have invested in Sensulin.

  • Who are Sensulin’s competitors?

    Sernova Biotherapeutics is a competitor of Sensulin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process